Webcast on Demand
On demand webcast: View the webcast from the Boehringer Ingelheim press conference at the ESC 2009 in Barcelona on 30 August.
Value through Innovation17 January 2013
Stroke Prevention in Atrial Fibrillation (SPAF) News and Information
This section includes information and resources about Stroke Prevention in Atrial Fibrillation (SPAF) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Stroke Prevention in Atrial Fibrillation (SPAF) Press Releases
| 27.10.2011 |
Boehringer Ingelheim implements additional guidance supporting appropriate use of Pradaxa® (dabigatran etexilate) in Europe - For European Health Media Only |
|---|---|
| 29.08.2011 |
€1 million awarded to winning projects which aim to prevent atrial fibrillation-related stroke - For non-UK and non-US media |
| 28.08.2011 |
Pradaxa® (dabigatran etexilate, 150mg bid) shows significant reduction in the risk of stroke over warfarin in patients with atrial fibrillation taking antiplatelet or other concomitant therapies - For NON-US and NON-UK Healthcare Media Only |
| 26.08.2011 |
Pradaxa® (dabigatran etexilate) revolutionizes stroke prevention in atrial fibrillation - For NON-US and NON-UK Healthcare Media Only |
| 04.08.2011 |
Breakthrough therapy PRADAXA® (dabigatran etexilate) first drug in 50 years to gain approval for stroke prevention in atrial fibrillation in EU - For NON-US and NON-UK Healthcare Media Only |
SPAF Related News Room
SPAF Related Documents
Videos
-
-
Prof. Gregory Lip
- Watch the video(QT)
-
-
-
-
-
-
-
-
-
-
-
